Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Heart Disease [Phase 1]

View source ↗

Summary

Phase 1 safety trial evaluating cultured allogeneic umbilical cord-derived mesenchymal stem cells for heart disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina
• Heart Failure

Drugs mentioned

• Cultured allogeneic umbilical cord-derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Congestive Heart Failure, Angina | Phase 1 | Status: TERMINATED